Status:
NOT_YET_RECRUITING
Comparison of Efficacy and Safety Between Ciprofol and Remimazolam During Fiberoptic Bronchoscopy
Lead Sponsor:
Anhui Provincial Hospital
Conditions:
Fiberoptic Bronchoscopy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Both ciprofol and remimazolam have been found to be potential alternatives to propofol (a commonly used anesthesia) during fiberoptic bronchoscopy, while the efficacy and safety between ciprofol and r...
Eligibility Criteria
Inclusion
- male or female patients with age ≥ 18 years old;
- scheduled to undergo bronchoscopy under laryngeal mask airway;
- with American Society of Anesthesiologists (ASA) physical status classes II to Ⅲ; and
- volunteering to participate in this study and signing an informed consent form.
Exclusion
- with contraindications to deep sedation/general anesthesia or with a history of sedation/anesthesia accidents;
- allergic to eggs, bean products, or experimental drugs (ciprofol, sufentanil, or remimazolam);
- difficult airway;
- with bradycardia or other serious cardiovascular diseases;
- with severe damages or diseases in important organs such as the lungs, brain, liver, or kidneys;
- using sedatives or antidepressants for a long time;
- pregnant or lactating women; and (8) unable to communicate or cooperate.
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2025
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT06531915
Start Date
December 1 2024
End Date
March 31 2025
Last Update
August 1 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.